Progyny, Inc.
PGNY
$32.60
$0.200.62%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 269.94M | 280.89M | 279.37M | 258.39M | 214.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 269.94M | 280.89M | 279.37M | 258.39M | 214.32M |
| Cost of Revenue | 213.05M | 218.27M | 218.73M | 199.75M | 169.83M |
| Gross Profit | 56.89M | 62.62M | 60.64M | 58.64M | 44.49M |
| SG&A Expenses | 43.09M | 44.44M | 45.46M | 43.63M | 41.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 256.14M | 262.70M | 264.19M | 243.38M | 211.02M |
| Operating Income | 13.80M | 18.19M | 15.18M | 15.01M | 3.31M |
| Income Before Tax | 16.26M | 20.93M | 17.17M | 16.33M | 4.14M |
| Income Tax Expenses | 2.79M | 5.03M | 2.18M | -1.35M | 733.00K |
| Earnings from Continuing Operations | 13.47M | 15.90M | 14.99M | 17.68M | 3.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.47M | 15.90M | 14.99M | 17.68M | 3.41M |
| EBIT | 13.80M | 18.19M | 15.18M | 15.01M | 3.31M |
| EBITDA | 14.43M | 18.77M | 15.71M | 15.55M | 3.75M |
| EPS Basic | 0.14 | 0.17 | 0.16 | 0.19 | 0.04 |
| Normalized Basic EPS | 0.09 | 0.13 | 0.10 | 0.11 | 0.03 |
| EPS Diluted | 0.14 | 0.16 | 0.15 | 0.18 | 0.03 |
| Normalized Diluted EPS | 0.09 | 0.12 | 0.10 | 0.10 | 0.02 |
| Average Basic Shares Outstanding | 95.98M | 95.50M | 94.74M | 93.83M | 93.06M |
| Average Diluted Shares Outstanding | 100.75M | 100.88M | 100.62M | 100.17M | 100.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
